ABIGAIL SVARPLAITIS: Open Payments
NPI 1467146860 · FAYETTEVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,267 in 66 payments from 24 companies in 2025. Trend: 2023 $0 · 2024 $800 · 2025 $1,267
Food & beverage: $1,267
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 12 | $185 |
| ABBVIE INC. | 8 | $146 |
| Novo Nordisk Inc | 9 | $138 |
| INTUITIVE SURGICAL, INC. | 1 | $110 |
| Astellas Pharma US Inc | 3 | $76 |
| Sumitomo Pharma America, Inc. | 4 | $73 |
| Exact Sciences Corporation | 4 | $72 |
| Axsome Therapeutics, Inc. | 3 | $65 |
| AstraZeneca Pharmaceuticals LP | 3 | $48 |
| Insulet Corporation | 2 | $45 |
Products named: Da Vinci Surgical System, MOUNJARO, Ozempic, Veozah, CREON, GEMTESA, Cologuard Collection Kit, Auvelity.
Industry payments across NY — which companies pay providers there.
